Author name: Leonardo Arias

Almost as many biotechs have opted for a reverse merger to reach the public markets as those executing more traditional initial public offerings this year.

Rotator cuff augmentation is one of the fastest-growing areas in sports medicine, according to Stryker.

An analysis of more than 550 million healthcare encounters from the EHR giant’s research division illuminates how restricting Medicaid coverage leaves low-income patients more directly on the hook for medical bills.

Focused on Medicaid, the new pacts now involve more than just large pharmaceutical companies.

  El contexto digital actual progresa a un ritmo acelerado, lo que incrementa las brechas de seguridad para que los ciberdelincuentes puedan ejecutar sus ataques. Ante esta situación, las empresas no quieren continuar con una actitud reactiva ante los incidentes informáticos. …

Roche has tapped Simcere Zaiming for a new T cell engager that could have broad application in B cell–mediated diseases including lymphoma and autoimmune conditions.

The diabetes tech firm is preparing for the launch of new devices, including a tubeless insulin pump and a fully closed loop automated insulin delivery system.

The medical device maker grew revenue by double digits in its fiscal first quarter, following fourth-quarter growth of nearly 10%.

GSK’s vaccine—which targets two primary flu antigens—elicited higher immune responses in both younger and older adults in a mid-stage study. The Phase 3 launch, planned for September, follows the FDA’s recent approval for Moderna’s mRNA flu vaccine.

The systems agreed to 10 years of state oversight and $600 million in investments as South Dakota-based Sanford moves into the Twin Cities.